Key Points
- Omada Health CFO Steven Cook sold 33,000 shares on June 26 at an average price of $19.89, totaling about $656,370. After the sale, he still held 133,359 shares valued at roughly $2.65 million.
- The company posted a smaller-than-expected loss in its latest quarterly earnings, reporting EPS of -$0.05 versus analyst expectations of -$0.08, on revenue of $78.05 million.
- Analyst sentiment remains moderately positive, with a consensus rating of “Moderate Buy” and an average price target of $22.91. Several firms recently maintained or raised ratings, though some targets were also cut.
Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) CAO Craig Gracey sold 2,084 shares of the firm's stock in a transaction that occurred on Friday, June 26th. The stock was sold at an average price of $20.00, for a total transaction of $41,680.00. Following the completion of the transaction, the chief accounting officer directly owned 2,941 shares in the company, valued at $58,820. This trade represents a 41.47% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Craig Gracey also recently made the following trade(s):
- On Monday, June 29th, Craig Gracey sold 2,083 shares of Omada Health stock. The shares were sold at an average price of $21.00, for a total value of $43,743.00.
- On Wednesday, June 24th, Craig Gracey sold 2,083 shares of Omada Health stock. The shares were sold at an average price of $19.01, for a total value of $39,597.83.
- On Monday, June 22nd, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $18.00, for a total value of $37,494.00.
- On Friday, June 12th, Craig Gracey sold 6,894 shares of Omada Health stock. The stock was sold at an average price of $17.42, for a total value of $120,093.48.
Omada Health Stock Up 1.3%
Shares of NASDAQ:OMDA opened at $21.95 on Wednesday. The business has a fifty day moving average of $16.83 and a two-hundred day moving average of $14.93. The stock has a market cap of $1.30 billion and a P/E ratio of -81.30. Omada Health, Inc. has a 52-week low of $10.28 and a 52-week high of $26.92.
Omada Health (NASDAQ:OMDA - Get Free Report) last posted its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.08) by $0.03. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%.The business had revenue of $78.05 million for the quarter. On average, equities analysts anticipate that Omada Health, Inc. will post -0.01 earnings per share for the current year.
Analyst Upgrades and Downgrades
A number of equities analysts have commented on the stock. Needham & Company LLC reaffirmed a "buy" rating and set a $28.00 target price on shares of Omada Health in a research note on Friday, May 8th. Citizens Jmp increased their price target on shares of Omada Health from $18.00 to $21.00 and gave the company a "market outperform" rating in a research note on Friday, May 8th. Morgan Stanley restated an "overweight" rating and set a $30.00 price target on shares of Omada Health in a report on Monday, June 22nd. Citigroup reaffirmed an "outperform" rating on shares of Omada Health in a research report on Friday, May 8th. Finally, Canaccord Genuity Group set a $24.00 price objective on Omada Health in a report on Friday, May 8th. Ten research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $22.91.
Check Out Our Latest Analysis on OMDA
Hedge Funds Weigh In On Omada Health
Several large investors have recently made changes to their positions in the stock. Geode Capital Management LLC acquired a new stake in Omada Health in the 2nd quarter valued at approximately $637,000. Walleye Capital LLC acquired a new position in Omada Health during the second quarter worth $458,000. Ilex Capital Partners UK LLP purchased a new position in shares of Omada Health during the second quarter worth $201,000. Soros Fund Management LLC acquired a new stake in shares of Omada Health in the second quarter valued at $640,000. Finally, Raymond James Financial Inc. acquired a new stake in shares of Omada Health in the second quarter valued at $32,000.
Omada Health Company Profile
(
Get Free Report)
Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company's platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.
In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
